<DOC>
	<DOC>NCT02011737</DOC>
	<brief_summary>The purpose of this study is to evaluate Efficacy and Safety of oral intake of Naftopidil 75mg once daily for the improving clearance of ureteral or renal stones.</brief_summary>
	<brief_title>Naftopidil 75mg for Improving Clearance of Urinary Stones</brief_title>
	<detailed_description>Prospective, Single-center, Double blind, Randomized controlled trial Treatment - Oral Naftopidil 75 mg once daily are given to the patients who are scheduled for shockwave lithotripsy (ESWL) because of ureteral or renal stones. Follow up Assessments including X-ray(KUB), visual analogue pain scale, are done 2, 4, and 6 weeks after the ESWL.</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Naftopidil</mesh_term>
	<criteria>Radioopaque (identifiable in KUB) ureter or kidney calculi size criteria is from 5mm to 15mm Symptomatic acute urinary tract infection during the runin period severe hydronephrosis 2 or more urinary stones Radiolucent (nonvisible in KUB) stone recent intervention for the urinary stone within 6 month Patients who have ureteral stent over 2.0 mg/dl of serum creatinine level severe hepatic dysfunction orthostatic hypotension current usage of alphaadrenergic blocker or calcium channel blocker Pregnant or nursing women Age under 15 year severe or uncontrolled medical conditions</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Medical Expulsive therapy</keyword>
</DOC>